STEPHANIE WHITE: Open Payments
NPI 1093476798 · MARSHALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 41 payments from 8 companies in 2025. Trend: 2023 $380 · 2024 $362 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $192 |
| Vanda Pharmaceuticals Inc. | 6 | $137 |
| Supernus Pharmaceuticals, Inc. | 14 | $132 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: COBENFY, FANAPT, Qelbree, CAPLYTA, SPRAVATO, ERZOFRI EXTENDED-RELEASE, INGREZZA, UZEDY.
Industry payments across TX — which companies pay providers there.
